KIMBERLY WARD: Open Payments
NPI 1861825135 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 33 payments from 8 companies in 2025. Trend: 2023 $1,106 · 2024 $365 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $230 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $142 |
| Astellas Pharma US Inc | 4 | $103 |
| Laborie Medical Technologies Corp. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| 180 Medical, Inc. | 1 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| COLOPLAST CORP | 1 | $14 |
Products named: MYFEMBREE, GEMTESA, Veozah, Mirena, EndoSheath Technology, SpeediCath.
Industry payments across NE — which companies pay providers there.
